Literature DB >> 15349692

[Ichthyoses and related keratinization disorders. Management, clinical features and genetics].

H Traupe1.   

Abstract

This review concerns ichthyoses and related keratinization disorders. These are rare genetic skin diseases which are associated with marked scaling, often considerable cutaneous inflammation and a severe disease burden both physically as well as psychosomatically. The review briefly discusses how to establish a clinical diagnosis, how to provide genetic counseling for the patient and their family and how to best manage such diseases. Particular emphasis is given to the new possibilities in diagnosis and treatment opened by the recently established network for ichthyoses and related keratinization disorders (NIRK). This network is funded by the German Ministry for Education and Research and aims to integrate research efforts into disease mechanisms and to spread and transfer knowledge about these diseases to achieve better clinical care for the patients.

Entities:  

Mesh:

Year:  2004        PMID: 15349692     DOI: 10.1007/s00105-004-0799-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  15 in total

1.  A novel in situ method for the detection of deficient transglutaminase activity in the skin.

Authors:  M Raghunath; H C Hennies; F Velten; V Wiebe; P M Steinert; A Reis; H Traupe
Journal:  Arch Dermatol Res       Date:  1998-11       Impact factor: 3.017

2.  Gas chromatography-mass spectrometry and molecular genetic studies in families with the Conradi-Hünermann-Happle syndrome.

Authors:  Cristina Has; Udo Seedorf; Frank Kannenberg; Leena Bruckner-Tuderman; Elzo Folkers; Regina Fölster-Holst; Ivo Baric; Heiko Traupe
Journal:  J Invest Dermatol       Date:  2002-05       Impact factor: 8.551

3.  The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3.

Authors:  G Richard; N Brown; L E Smith; A Terrinoni; G Melino; R M Mackie; S J Bale; J Uitto
Journal:  Hum Genet       Date:  2000-03       Impact factor: 4.132

4.  Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1.

Authors:  Florence Jobard; Caroline Lefèvre; Aysen Karaduman; Claudine Blanchet-Bardon; Serap Emre; Jean Weissenbach; Meral Ozgüc; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

5.  Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.

Authors:  Nahoko Komatsu; Minoru Takata; Norio Otsuki; Rie Ohka; Osamu Amano; Kazuhiko Takehara; Kiyofumi Saijoh
Journal:  J Invest Dermatol       Date:  2002-03       Impact factor: 8.551

6.  HID and KID syndromes are associated with the same connexin 26 mutation.

Authors:  M van Geel; M A M van Steensel; W Küster; H C Hennies; R Happle; P M Steijlen; A König
Journal:  Br J Dermatol       Date:  2002-06       Impact factor: 9.302

7.  Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy.

Authors:  B C Broughton; H Steingrimsdottir; C A Weber; A R Lehmann
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

8.  Further delineation of the ichthyosis follicularis, atrichia, and photophobia syndrome.

Authors:  H Hamm; P Meinecke; H Traupe
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

9.  SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.

Authors:  Michael Raghunath; Lambrini Tontsidou; Vinzenz Oji; Karin Aufenvenne; Funda Schürmeyer-Horst; Arumugam Jayakumar; Hartmut Ständer; Josef Smolle; Gary L Clayman; Heiko Traupe
Journal:  J Invest Dermatol       Date:  2004-09       Impact factor: 8.551

10.  Autosomal dominant lamellar ichthyosis: a new skin disorder.

Authors:  H Traupe; G Kolde; R Happle
Journal:  Clin Genet       Date:  1984-11       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.